Outsourcing

Articles

Cambrex will create a new center of excellence for API process development and clinical supply at its High Point, NC facility and expand its API manufacturing facility in Italy. 

Cambrex Development Center in North Carolina Focuses on Continuous Flow

According to CPhI’s annual report, the therapeutic antibody drug conjugates (ADC) market is expected to reach $4 billion by 2023.

CMOs to Benefit from Double-Digit Approvals for ADCs, CPhI Reports

Clovis Oncology and Lonza celebrated the grand opening of a dedicated production train at Lonza’s Visp, Switzerland site for manufacturing Rubraca (rucaparib).

Lonza Opens Monoplant for Clovis Oncology’s Rubraca

The company says the new equipment will reduce sample turnaround times and increase variant detection quality and accuracy.

Almac Invests in Next-Generation Sequencing Capabilities

The new facility will include comprehensive mammalian process development and manufacturing capabilities.

AGC Biologics Adds Mammalian Production Capacity in Japan

At this year’s CPhI Worldwide congress in Madrid, Spain, Archer Daniels Midland Company (ADM) will present its range of products spanning probiotics and microbiome solutions to highly purified, injectable-grade vegetable oils.

ADM to Present Extended Health and Wellness Offering at CPhI 2018

Luxembourg-based pharmaceutical group, C2 Pharma (formerly known as Centroflora CMS) successfully validated the manufacturing process for two APIs-digoxin and digoxin micron.

C2 Pharma Validates Manufacturing Process for Two APIs and Enters Strategic Partnership with Theracule

Rentschler Fill Solutions received a certificate of GMP compliance from the Austrian Agency for Health and Food Safety for its new aseptic fill/finish facility.

Rentschler Fill Solutions Starts GMP Operations in Austria

Susan Haigney is lead editor of Pharmaceutical Technology and Pharmaceutical Technology Europe.

Industry experts discuss the formulation and development issues that should be considered when addressing scale up from small-scale batches to commercial production.

Outsourcing Development: Small-Scale to Commercial

Vetter chose a winner from four teams that worked for three months to develop ideas for applying digital technology to injectable pharmaceuticals. 

Contract Manufacturing Services